StockDrifts LogoStockDrifts

Jinjin Biopharm 110020

Company
전진바이오팜Jinjin Biopharm
Insiders
1
Buys
124
Total Value
₩170M ($118K)
Avg Return
-4.97%
Last Filing
2026-06-10

Jinjin Biopharm (110020) has 124 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩170M ($118K) in reported transaction value. The earliest filing StockDrifts holds for Jinjin Biopharm is dated 2024-05-08; the most recent is 2026-06-10. Across these filings the average return since disclosure is -4.97%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO6₩1,972+0.9%₩12K ($8)
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO781₩1,972+0.9%₩2M ($1K)
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO635₩1,972+0.9%₩1M ($884)
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO326₩1,972+0.9%₩650K ($452)
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO316₩1,972+0.9%₩632K ($439)
2026-08-21BUYMarket Buy
이태훈
Taehoon Lee
CEO14₩1,972+0.9%₩28K ($19)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO150₩2,000-0.6%₩300K ($208)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO50₩2,000-0.6%₩100K ($70)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO1₩2,000-0.6%₩2K ($1)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO26.2K₩2,000-0.6%₩58M ($40K)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO932₩2,000-0.6%₩2M ($1K)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO240₩2,000-0.6%₩484K ($336)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO228₩2,000-0.6%₩462K ($321)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO181₩2,000-0.6%₩366K ($254)
2026-08-20BUYMarket Buy
이태훈
Taehoon Lee
CEO179₩2,000-0.6%₩363K ($252)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO336₩2,010-1.0%₩734K ($510)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO175₩2,010-1.0%₩369K ($256)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO143₩2,010-1.0%₩286K ($199)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO101₩2,010-1.0%₩221K ($154)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO100₩2,010-1.0%₩212K ($147)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO69₩2,010-1.0%₩137K ($95)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO42₩2,010-1.0%₩88K ($61)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO21.8K₩2,010-1.0%₩46M ($32K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO4.6K₩2,010-1.0%₩10M ($7K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO2.9K₩2,010-1.0%₩6M ($4K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO2.4K₩2,010-1.0%₩5M ($3K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.7K₩2,010-1.0%₩3M ($2K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.6K₩2,010-1.0%₩3M ($2K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.5K₩2,010-1.0%₩3M ($2K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.4K₩2,010-1.0%₩3M ($2K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.0K₩2,010-1.0%₩2M ($1K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO1.0K₩2,010-1.0%₩2M ($1K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO998₩2,010-1.0%₩2M ($1K)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO502₩2,010-1.0%₩1M ($696)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO440₩2,010-1.0%₩970K ($674)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO477₩2,010-1.0%₩961K ($667)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO11₩2,010-1.0%₩24K ($17)
2026-08-19BUYMarket Buy
이태훈
Taehoon Lee
CEO10₩2,010-1.0%₩20K ($14)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO5₩2,010-1.0%₩10K ($7)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO151₩2,010-1.0%₩301K ($209)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO123₩2,010-1.0%₩244K ($170)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO113₩2,010-1.0%₩226K ($157)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO111₩2,010-1.0%₩222K ($154)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO100₩2,010-1.0%₩203K ($141)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO100₩2,010-1.0%₩199K ($138)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO94₩2,010-1.0%₩190K ($132)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO75₩2,010-1.0%₩149K ($104)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO63₩2,010-1.0%₩123K ($85)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO50₩2,010-1.0%₩99K ($69)
2026-08-18BUYMarket Buy
이태훈
Taehoon Lee
CEO46₩2,010-1.0%₩91K ($63)

Showing the 50 most recent of 200 filings.

Frequently asked questions

Who has been buying Jinjin Biopharm stock?
1 distinct insiders have filed 124 disclosed insider purchases in Jinjin Biopharm (110020), most recently on 2026-06-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Jinjin Biopharm have?
Jinjin Biopharm has 124 buy-side and 0 sell-side disclosures on record, covering ₩170M ($118K) in total reported value, spanning 2024-05-08 to 2026-06-10.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.